Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025HaematologicaOpen Access

HES1 regulates bone marrow mesenchymal stromal cell function by suppressing NFATc2-mediated inflammation

View Full Paper
Ask AI
Bookmark
Share

Authors

AZAnthony Z. ZhuZMZhilin MaEWEmily V. Wolff

Discussion

Loading...

Member takes

Overview

Observational analysis shows HES1 influences inflammation in mesenchymal stromal cells, suggesting potential therapeutic targets.

Key Points

  • HES1 is crucial for maintaining bone marrow mesenchymal stromal cell homeostasis, especially under stress.
  • Deletion of Hes1 in bone marrow reduces mesenchymal stromal cell frequency and impairs hematopoiesis support.
  • Pharmacological inhibition of inflammation can rescue Hes1-KO mesenchymal stromal cell functions.
  • Research reveals HES1's role in regulating NFATc2 to suppress inflammation in bone marrow stromal cells.

Cite This Study

Zhu et al. (2025) studied this question.

synapsesocial.com/papers/68e040f3a99c246f578b3885https://doi.org/10.3324/haematol.2025.288138
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hes1 in malignant tumors: from molecular mechanism to therapeutic potential2025 · 4 citations
  2. 2Title: Hacs1 is a myeloma immunosuppressor driving pro-tumorigenic myelopoiesis and myeloid cell differentiation through MS4A3/IL3/GM-CSF signaling2025
  3. 3Endothelial SRSF1 regulates hematopoietic stem cell function in the bone marrow microenvironment2025
  4. 4Endothelial cell-derived thrombospondin-1 negatively affects hematopoietic function during aging2025
  5. 5Targeting ephrin A3 in the bone marrow niche offers a promising therapeutic strategy to impede hematopoietic stem cell maintenance in MDS patients2025